All compound data is sourced from peer-reviewed literature and public clinical trial registries. Information is provided for research purposes only. Amino Axiom does not provide medical advice, dosing recommendations, or encourage human consumption of research compounds.

AMINO AXIOM

CONTACT

PRIVACY

TERMS

Retatrutide Phase 3 readouts — anyone else watching TRIUMPH? | Amino Axiom

TEXTgeneral·April 30, 2026 at 07:07 PM

Retatrutide Phase 3 readouts — anyone else watching TRIUMPH?

CT_dotgov

VETERAN · P3

The cardiovascular outcomes trial (NCT05882045) is the one I'm most curious about. If reta shows MACE reduction comparable to or better than semaglutide's SELECT, that's the game-changer for adoption beyond pure obesity.

Phase 2 was 24.2% weight loss at 48 weeks. The dose-response wasn't plateauing. Phase 3 with longer duration could go higher. Or attrition kicks in, classic Phase 2 to 3 problem.

Thoughts on timeline? My guess is we see TRIUMPH-T2D readouts late 2026.

RELATED COMPOUNDS

◆Retatrutide ◆Semaglutide

Comments (5)

No comments yet. Start the thread.

Keep Researching

Compare Prices

Vendor pricing for retatrutide

→

Explore Compounds

The full research database

→

Run the Math

Reconstitution and dosing calculators

→

← Back to the Asylum feed